(Q36773912)

16 August 2017

1 reference

title

Endocrine emergencies. Hypoglycaemia (English)

1 reference

16 August 2017

1 reference

Binder C

1

1 reference

16 August 2017

Bendtson I

series ordinal

2

1 reference

16 August 2017

publication date

1 January 1992

1 reference

Bailliere's clinical endocrinology and metabolism

16 August 2017

published in

1 reference

16 August 2017

volume

6

1 reference

16 August 2017

issue

1

1 reference

16 August 2017

page(s)

23-39

1 reference

Hypoglycemia owing to inappropriate glucagon secretion treated with a continuous subcutaneous glucagon infusion system.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Glibenclamide-associated hypoglycaemia: a report on 57 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Insulin resistance in type 1 (insulin-dependent) diabetes following hypoglycaemia--evidence for the importance of beta-adrenergic stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Counterregulatory hormonal response to insulin-induced hypoglycaemia in insulin-dependent diabetic patients: a comparison of equimolar amounts of porcine and semisynthetic human insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Incidence of nocturnal hypoglycaemia in insulin-dependent diabetic patients on intensive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Skin nerve sympathetic activity during insulin-induced hypoglycaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Abnormal Glucose Counterregulation after Subcutaneous Insulin in Insulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Autoimmunity to insulin receptor and hypoglycaemia in patient with Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Comparison of intravenous glucagon and dextrose in treatment of severe hypoglycemia in an accident and emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Facilitated transfer of glucose from blood into brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

The Evolving Clinical Course of Patients with Insulin Receptor Autoantibodies: Spontaneous Remission or Receptor Proliferation with Hypoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Hyperglycemia, hypoglycemic attacks, and production of anti-insulin antibodies without previous known immunization. Immunological and functional studies in a patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Blood-brain glucose transfer: repression in chronic hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Hypoglycaemic reactions in 172 Type 1 (insulin-dependent) diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Diabetic control and microvascular complications: the near-normoglycaemic experience

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Responses to human and porcine insulin in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Hypoglycaemia after propranolol in children

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Haemodynamic changes in insulin-induced hypoglycaemia in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Altered recognition of hypoglycaemic symptoms in type I diabetes during intensified control with continuous subcutaneous insulin infusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Transient atrial fibrillation precipitated by hypoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Hypoglycemia due to apparent autoantibodies to insulin. Characterization of insulin-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Nocturnal hypoglycaemia in patients receiving conventional treatment with insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Cognitive function during hypoglycaemia in type I diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

The relationship between symptomatic and biochemical hypoglycaemia in insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Symptomatic Hypoglycaemia in 411 Type 1 Diabetic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Increased insulin-like growth factor II production and consequent suppression of growth hormone secretion: a dual mechanism for tumor-induced hypoglycemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Indomethacin and hypoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Monitoring of blood glucose concentration in subjects with hypoglycaemic symptoms during everyday life

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Duration of hypoglycemia and need for intravenous glucose following intentional overdoses of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

The influence of different insulin regimens on quality of life and metabolic control in insulin-dependent diabetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Neurophysiological changes during insulin-induced hypoglycaemia and in the recovery period following glucose infusion in type 1 (insulin-dependent) diabetes mellitus and in normal man.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulin-like growth factor I in the diagnosis of non-islet cell tumour hypoglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Frequency of daytime biochemical hypoglycaemia in insulin-treated diabetic patients: relation to daily median blood glucose concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

Standard Parameters of Diabetic Control: Are They Reliable?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980329-5

7 January 2021

10.1016/S0950-351X(05)80329-5

Identifiers

DOI

1 reference

16 August 2017

1 reference